We are hiring
22. November 2023
At the Berne location, we are looking for a Lawyer (80 - 100%) and for a Office Manager (80 - 100%). More about this.
BGPartner advises Memo Therapeutics Ltd on its CHF 25 million Series C financing round
02. November 2023
Memo Therapeutics Ltd is a late-stage biotech company developing best-in-class therapeutic antibodies to transform the lives of patients with virus infections and cancer. MTx will use the proceeds to complete U.S. Phase II clinical development of its best- and first-in-class antibody, AntiBKV, intended to neutralize BK polyomavirus (BKV) infection in kidney transplant recipients.
The Series C financing round was led by Pureos Bioventures. Existing investors Swisscanto, Vesalius Biocapital, Adjuvant Capital, Verve Ventures, Schroders Capital, GF Group, Fresenius Medical Care Ventures and Red Alpine joined in the round.
The BGPartner team assisting Memo Therapeutics Ltd in all legal and negotiation matters was led by Oliver Gnehm (Partner) and further consisted of Victoria Marty (Associate) and Barbara Meise (Associate).
BGPartner is a top Swiss law firm in the area of Private Equity and Venture Capital and has won various awards.
Click here for the complete media release.
More information about our legal and negotiation expertise can be found here.
18. October 2023
BGPartner advised the owners of TSE Troller AG on the successful sale of their 100% shareholding in TSE Troller AG. TSE Troller AG is a leading international company with over 60 years of experience in the development and manufacturing of high-quality coating nozzles and is headquartered in Murgenthal AG.
The buyer is Indutrade AB, an industrial group listed on Nasdaq Stockholm with over 200 companies in around 30 countries.
BGPartner advised the sellers strategically and operationally on all legal issues throughout the entire sales process up to the successful signing and closing of the transaction and led the negotiations.
The BGPartner team was led by Olivier Bula (Partner).
New team member
05. October 2023
Interview from the Finanz und Wirtschaft
19. September 2023
"How can Swiss negotiation practice still be improved?" The answer to this and other questions is provided by BGPartner negotiation experts Oliver Gnehm and Elena Mégevand in an interview with Finanz und Wirtschaft. The interview is based on the study "How do Swiss executives negotiate?". The first, scientifically based practical study on the negotiation behavior of Swiss executives. Conducted by BGPartner in cooperation with the Negotiation Academy Potsdam (NAP). Download article as PDF.